Today's Date: December 17, 2014 Search | Home | Contact | Services | Patent Attorney | Patent Search | Provisional Patent Application | Patent Application | Software Patent | Confidentiality Agreements

Posts Tagged ‘ justice sotomayor ’

Supremes Say Broad Discretion to District Courts to Award Attorneys Fees

Posted: Tuesday, Apr 29, 2014 @ 6:08 pm | Written by Gene Quinn | 2 comments
| Tags: , , , , , , , , , , ,
Posted in: Federal Circuit, Gene Quinn, Government, IP News, Articles, Patent Litigation, Patents, US Supreme Court

Justice Sonia Sotomayor delivered the opinion for the Court.

Earlier today the United States Supreme Court shed significant light into the question of awarding attorneys fees under 35 U.S.C. § 285 to successful litigants in a patent infringement proceeding. The decision in Octane Fitness, LLC v. ICON Health & Fitness, Inc., was the primary decision of the day simply because that case was treated first by the Court and formed the basis of the Court’s decision in Highmark, Inc. v. Allcare Health Management System, Inc. Essentially, in Highmark, the Supreme Court found that the ruling in Octane was dispositive that that “an appellate court should apply an abuse-of-discretion standard in reviewing all aspects of a district court’s § 285 determination.”

35 U.S.C. § 285, which is an extremely short statute, authorizes a district court to award attorney’s fees in patent litigation to the prevailing party. In its totality, § 285 states: “[t]he court in exceptional cases may award reasonable attorney fees to the prevailing party.” With such a simple statute you might wonder how or why it was necessary for the Supreme Court to step in and provide clarity. Because in 2005 the Federal Circuit departed from three decades of case law and made it difficult, if not impossible, for prevailing parties to demonstrate entitlement to attorneys fees.

In Brooks Furniture Mfg., Inc. v. Du­ tailier Int’l, Inc., 393 F. 3d 1378 (2005), the United States Court of Appeals for the Federal Circuit held that “[a] case may be deemed exceptional” under § 285 only in two situations: (1) “when there has been some material inappropriate conduct,” or (2) when the litigation is both “brought in subjective bad faith” and “objectively baseless.” The question put before the Supreme Court was whether the Brooks Furniture framework is consistent with the statutory text.

Intel Patents: A Diverse Story of Software Innovation

Posted: Sunday, Apr 20, 2014 @ 1:29 pm | Written by Steve Brachmann | Comments Off
| Tags: , , , , , , , , , , ,
Posted in: Authors, Companies We Follow, Intel, IP News, Articles, Mobile Devices, Patents, Software, Technology & Innovation

The Intel Corporation of Santa Clara, CA, has been a global leader in the development of computing processors and related semiconductor components for the past few decades. In 2013, this technology manufacturer saw a drop in revenues but still maintained 15.4 percent of the world’s market share for semiconductors, making it the top corporation overall in that respect. New Intel chipset products are set to hit technology markets in May 2014, which could result in upgrades to the Apple iMacs using these processors. Intel’s also developing improvements to its Thunderbolt Networking technology allowing for easy connection of computers running different operating system platforms, supporting PC-to-Mac connections.

Our Companies We Follow series has looked at Intel a few times before. Our latest chance to check in with this multinational semiconductor chip manufacturer has revealed some truly unique technologies meant to improve mobile devices and communication systems for a great number of global consumers. Software is the common theme behind those patents and patent application we found during this snapshot look at Intel.

We start our profile of Intel’s recently developed technologies with a look at our featured patent application, which discusses a novel system for managing access to a vehicle among multiple drivers. This access management system would also be able to delegate responsibilities, such as gas refueling and scheduled maintenance, as well as enable emergency access to trusted parties. Other patent applications which we noticed today discussed enhanced security measures for private data as well as home media systems for accessing segmented television content.

Supremes Say Reverse Payments May Be Antitrust Violation

Posted: Tuesday, Jun 18, 2013 @ 6:00 am | Written by Gene Quinn | 3 comments
| Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Posted in: Antitrust, Food & Drug Administration, Gene Quinn, IP News, Articles, Patents, Pharmaceutical, US Supreme Court

Justice Stephen Breyer wrote for the majority in FTC v. Actavis.

On Monday, June 17, 2013, the United States Supreme Court issued its much-anticipated decision on so-called “reverse payments” in FTC v. Actavis, Inc.  This decision will impact how brand name drug companies and generics enter into patent settlements to resolve pending patent litigation.  In a nutshell, speaking for the majority, Justice Breyer wrote that there is no valid reason for the FTC to be denied the opportunity to pursue reverse payments as an antitrust violation.  Breyer, who was joined by Justices Kennedy, Ginsberg, Kagan, and Sotomayor, determined that reviewing courts should apply the rule of reason when determining whether reverse payments violate antitrust law.

While the ruling will likely come as no shock to casual observers, or even to those who have long believed that these agreements were anticompetitive, it is a bit of a shock in that the decision seems to present an unrealistic utopian view of how challenges to reverse payments will be litigated.  For reasons hardly explained, Breyer thinks that it will be largely unnecessary for reviewing courts to engage in complicated review of the patent or to engage patent issues, but at the heart of these cases is the underlying patent and associated patent laws that give brand name manufacturers significant and uncompromised rights to exclude.

Chief Justice Roberts explained in his dissent, who was joined by Justices Scalia and Thomas, that it was his view the decision of the majority “weakens the protections afforded to innovators by patents, frustrates the public policy in favor of settling, and likely undermines the very policy it seeks to promote by forcing generics who step into the litigation ring to do so without the prospect of cash settlements.”

Argument Summary: Supreme Court Hears Bowman v. Monsanto

Posted: Wednesday, Feb 20, 2013 @ 2:54 pm | Written by Gene Quinn | 15 comments
| Tags: , , , , , , , , , , , , , ,
Posted in: Biotechnology, Gene Quinn, IP News, Articles, Patents, US Supreme Court

U.S. Supreme Court. © Gene Quinn, 2009.

Yesterday, the United States Supreme Court heard oral arguments in the matter of Bowman v. Monsanto. See Transcript. The case presents the Court a question of patent infringement by farmers planting the progeny of genetically altered seeds covered by U.S. patents.

Monsanto Company and Monsanto Technology LLC (collectively “Monsanto”), sued Vernon Hugh Bowman (“Bowman”), in the United States District Court for the Southern District of Indiana alleging infringement of U.S. Patent Nos. 5,352,605 (“’605 Patent”) and RE39,247E (“’247E Patent”). The district court granted summary judgment of infringement in favor of Monsanto. Bowman appealed to the United States Court of Appeals for the Federal Circuit, which affirmed the district court judgment in favor of Monsanto. See Monsanto v. Bowman (CAFC, Sept. 21, 2011).

Bowman then appealed to the United States Supreme Court, with oral argument in the matter being held on February 19, 2013. While one can never know for certain how the Supreme Court will rule, even a casual observer has to conclude that the Supreme Court seems poised rule in favor of Monsanto. Seconds after Bowman’s attorney started Chief Justice Roberts interrupted asking why anyone would ever patent anything if Bowman were to prevail. Shortly thereafter Justice Breyer openly concluded that Bowman infringed in a matter of fact way. It later may have seemed Breyer was probing for a response he didn’t get more so than announcing his view of the case. Nevertheless, if Bowman loses Breyer he has no chance.

Supreme Court Hears Oral Argument in Mayo v. Prometheus

Posted: Wednesday, Dec 7, 2011 @ 11:29 pm | Written by Gene Quinn | 20 comments
| Tags: , , , , , , , , , , , , , , ,
Posted in: Gene Quinn, IP News, Articles, Patentability, Patents, US Supreme Court

Earlier today, at 10:05 am precisely, the United States Supreme Court heard oral arguments in the case styled Mayo Collaborative Services v. Prometheus Laboratories.  A press release issued by the AIPLA sums the cautious optimism of many: the Supreme Court “appeared to move closer to the Federal Circuit’s understanding of patent eligible subject matter.”  Of course, no one will really know for some time, and there is certainly enough reason to worry after the oral argument.  Predictably Justice Breyer seems ready to rule virtually all process claims unpatentable, and surprisingly Chief Justice Roberts seemed more in agreement with Breyer than anyone else.

In all likelihood it will be at least a couple months before we know the outcome of this case, which holds in the balance the future of medical treatment claims.  In fact, the average length of time for the Supreme Court to decide patent cases since Markman in 1996 is about 3 months.  The most recent Supreme Court cases have lingered on average over 5 months.  How the Supreme Court operates is one of the better mysteries in our form of government, and there will be absolutely no signaling of when to expect a decision.  The Supreme Court will just one day announce a decision.  Notwithstanding, I’m going to hazard a guess that we will have a decision between the end of March 2012 and the end of May 2012.  I don’t see this as an end of the term opinion.

Present Assignment of Future Invention Rights: Some Heretical Thoughts on the Stanford Case*

Posted: Thursday, Jul 14, 2011 @ 11:18 am | Written by Eric Guttag | 10 comments
| Tags: , , , , , , , , , , , , , , , , , , , , , , ,
Posted in: Authors, Eric Guttag, Federal Circuit, IP News, Articles, Licensing, Patent Litigation, Patents, Technology Transfer, US Supreme Court

In my earlier article addressing the Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc., I suggested the Federal Circuit “still doesn’t get it” on how title to “subject inventions” works under Bayh-Dole.  See CAFC Continues to Struggle with How Title to Subject Inventions Works under Bayh-Dole.  My original view was that the title to the “subject inventions” (i.e., those resulting from federally sponsored research) initially resided with the organization (e.g., Stanford University) which carried out the sponsored research. I now confess that I, like Stanford University, overstated how Bayh-Dole works with regard to title to “subject inventions.”  In affirming the Federal Circuit, a majority of the Supreme Court (6 Justices) later ruled that Bayh-Dole “does not automatically vest title to federally funded inventions in federal contractors or authorize contractors to unilaterally take title to such inventions.”  See head notes to the Supreme Court’s slip opinion.

Clear & Convincing: Supreme Court Affirms CAFC in Microsoft v. i4i

Posted: Thursday, Jun 9, 2011 @ 12:18 pm | Written by Gene Quinn | 13 comments
| Tags: , , , , , , , , , , ,
Posted in: Companies We Follow, Federal Circuit, Gene Quinn, IP News, Articles, Microsoft, Patent Litigation, Patents, US Supreme Court

Justice Sonia Sotomayor

UPDATED: 6/10/2011 @ 12:28pm (see comments)

Earlier today the United States Supreme Court issued its decision in Microsoft v. i4i.  At stake in this closely watched case was whether a patent would continue to carry a strong presumption of validity during litigation or whether that presumption of validity would be significantly weakened.  More specifically, since the inception of the Federal Circuit the law has always been that to overturn the presumption of validity required by 35 U.S.C. 282 and invalidate a patent claim there needs to be clear and convincing evidence presented at trial, regardless of whether the prior art offered at trial was considered by the Patent Office.

Microsoft (NASDAQ:MSFT) wanted to see that changed, with prior art not considered by the Patent Office requiring a lower evidentiary threshold to invalidate. To rule in Microsoft’s favor would have required the Supreme Court to throw away 30 years of well-settled Federal Circuit law, as well as overruling Supreme Court precedent in effect since at least 1934, but which traces back in some form from that date a further 100 years.  That was a bridge too far for the Supreme Court, who ruled today 8-0 (with concurring opinions but no dissents, and with Chief Justice Roberts taking no part in the decision) that in order to invalidate patent claims 35 U.S.C. 282 requires clear and convincing evidence regardless of whether the prior art was known by the Patent Office during prosecution of the patent application.

Supreme Court Affirms CAFC in Stanford v. Roche on Bayh-Dole

Posted: Monday, Jun 6, 2011 @ 12:02 pm | Written by Gene Quinn | 30 comments
| Tags: , , , , , , , , , , , , , , , , ,
Posted in: Federal Circuit, Gene Quinn, IP News, Articles, Patents, US Supreme Court

This morning the United States Supreme Court issued its decision in Stanford v. Roche, a decision that has been much anticipated in the technology transfer world.  Technology transfer is the front line for the interfacing of University research and private sector commercialization, so it is no great wonder that this case captured the attention of academia and the private sector alike. At issue in the case was whether the Bayh-Dole Act automatically vested ownership of patent rights in Universities when the underlying research was federally funded.

Chief Justice Roberts delivered the opinion in a 7-2 decision.

It is not at all an exaggeration to say that Bayh-Dole is one of the most successful pieces of domestic legislation ever enacted into law. The Bayh-Dole Act, which was enacted on December 12, 1980, was revolutionary in its outside-the-box thinking, creating an entirely new way to conceptualize the innovation to marketplace cycle. It has lead to the creation of 7,000 new businesses based on the research conducted at U.S. Universities. Prior to the enactment of Bayh-Dole there was virtually no federally funded University technology licensed to the private sector, no new businesses and virtually no revolutionary University innovations making it to the public. Bayh-Dole set out to remedy this situation, and as a direct result of the passage of Bayh-Dole countless technologies have been commercialized, including many life saving cures and treatments for a variety of diseases and afflictions. In fact, the Economist in 2002 called Bayh-Dole the most inspired and successful legislation over the previous half-century. Nevertheless, the question remained, at least until this morning, whether ownership of patent rights immediately vested in the University as the result of federal funding.

Microsoft i4i Oral Arguments Complete at Supreme Court

Posted: Monday, Apr 18, 2011 @ 4:15 pm | Written by Gene Quinn | 32 comments
| Tags: , , , , , , , , , , , , , , , , , , , , , ,
Posted in: Companies We Follow, Gene Quinn, IP News, Articles, Microsoft, Patent Litigation, Patents, US Supreme Court

Justice Scalia, who presided over the Court in Microsoft v. i4i

At 11:03 am this morning Justice Scalia, sitting in for the recused Chief Justice John Roberts, called the most recent Supreme Court foray into patent law saying: “We’ll hear argument now in… Microsoft Corporation v. i4i Limited Partnership.”  The Chief Justice recuses himself from any and all Microsoft cases before the Supreme Court, so eight Justices are left to decide whether it is appropriate to require clear and convincing evidence to find an issued patent claim invalid during litigation.  In a nutshell, Microsoft and the amici supporting Microsoft would rather have a lower threshold (i.e., preponderance of the evidence) at least with respect to prior art that was not considered by the patent examiner during prosecution of the patent application at the United States Patent and Trademark Office.  On the other side of the case, i4i, along with its amici and the Solicitor General, argue that the current standard should not be changed.

Supreme Court Hears Arguments in Costco Copyright Case

Posted: Tuesday, Nov 9, 2010 @ 4:03 pm | Written by Gene Quinn | 9 comments
| Tags: , , , , , , , , , , , , , , , ,
Posted in: Copyright, Gene Quinn, IP News, Articles, US Supreme Court

Image take from Costco's brief, showing the copyrighted Omega Globe in question in perspective.

Yesterday the United States Supreme Court heard oral arguments in the case of Costco Wholesale Corporation v. Omega S.A.  The case is a copyright dispute that adds one layer of additional facts not considered by the Supreme Court in their 1998 ruling in Quality King Distribs., Inc. v. L’anza Research Int’l, Inc.

The dispute arose because Omega, S.A., sought to prevent the petitioner, Costco Wholesale Corporation, from reselling genuine watches originally sold by Omega to authorized foreign distributors. Omega, a Swiss company that manufactures watches in Switzerland, did not authorize the importation of the watches by Costco, despite the fact that Costco legally purchased the watches abroad. Thus, the question in this case will be whether copyrighted materials made abroad and legally purchased abroad can be imported without the express permission of the copyright owner. In other words, does the first sale doctrine extinguish the rights of the copyright holder when the goods are made abroad and sold abroad.